vs
Fluent, Inc.(FLNT)与RECURSION PHARMACEUTICALS, INC.(RXRX)财务数据对比。点击上方公司名可切换其他公司
Fluent, Inc.的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.7倍($61.8M vs $35.5M),Fluent, Inc.净利率更高(-6.7% vs -304.2%,领先297.6%),RECURSION PHARMACEUTICALS, INC.同比增速更快(681.7% vs -5.5%),过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高(60.5% vs -3.2%)
THG Fluently前身为Language Connect,是THG Ingenuity旗下的翻译与语言本地化服务品牌,可为客户提供笔译、口译、本地化、配音、转录以及多语种搜索引擎优化等一系列语言相关服务,满足全球客户不同场景的多元语言需求。
Recursion Pharmaceuticals是一家临床阶段生物技术企业,依托人工智能技术和高通量生物实验体系,开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法,核心市场覆盖北美,与全球多家生物制药企业合作推进在研管线落地。
FLNT vs RXRX — 直观对比
营收规模更大
FLNT
是对方的1.7倍
$35.5M
营收增速更快
RXRX
高出687.2%
-5.5%
净利率更高
FLNT
高出297.6%
-304.2%
两年增速更快
RXRX
近两年复合增速
-3.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $61.8M | $35.5M |
| 净利润 | $-4.1M | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | 0.3% | -304.8% |
| 净利率 | -6.7% | -304.2% |
| 营收同比 | -5.5% | 681.7% |
| 净利润同比 | -20.1% | 39.6% |
| 每股收益(稀释后) | $-0.09 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
FLNT
RXRX
| Q4 25 | $61.8M | $35.5M | ||
| Q3 25 | $47.0M | $5.2M | ||
| Q2 25 | $44.7M | $19.2M | ||
| Q1 25 | $55.2M | $14.7M | ||
| Q4 24 | $65.4M | $4.5M | ||
| Q3 24 | $64.5M | $26.1M | ||
| Q2 24 | $58.7M | $14.4M | ||
| Q1 24 | $66.0M | $13.8M |
净利润
FLNT
RXRX
| Q4 25 | $-4.1M | $-108.1M | ||
| Q3 25 | $-7.6M | $-162.3M | ||
| Q2 25 | $-7.2M | $-171.9M | ||
| Q1 25 | $-8.3M | $-202.5M | ||
| Q4 24 | $-3.4M | $-178.9M | ||
| Q3 24 | $-7.9M | $-95.8M | ||
| Q2 24 | $-11.6M | $-97.5M | ||
| Q1 24 | $-6.3M | $-91.4M |
毛利率
FLNT
RXRX
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
营业利润率
FLNT
RXRX
| Q4 25 | 0.3% | -304.8% | ||
| Q3 25 | -13.4% | -3327.6% | ||
| Q2 25 | -15.9% | -916.8% | ||
| Q1 25 | -12.8% | -1297.9% | ||
| Q4 24 | -8.3% | -4042.4% | ||
| Q3 24 | -6.0% | -377.1% | ||
| Q2 24 | -17.7% | -697.4% | ||
| Q1 24 | -6.0% | -698.4% |
净利率
FLNT
RXRX
| Q4 25 | -6.7% | -304.2% | ||
| Q3 25 | -16.1% | -3135.3% | ||
| Q2 25 | -16.2% | -894.2% | ||
| Q1 25 | -15.0% | -1373.3% | ||
| Q4 24 | -5.2% | -3935.5% | ||
| Q3 24 | -12.3% | -367.5% | ||
| Q2 24 | -19.8% | -676.6% | ||
| Q1 24 | -9.5% | -662.4% |
每股收益(稀释后)
FLNT
RXRX
| Q4 25 | $-0.09 | $-0.17 | ||
| Q3 25 | $-0.27 | $-0.36 | ||
| Q2 25 | $-0.30 | $-0.41 | ||
| Q1 25 | $-0.39 | $-0.50 | ||
| Q4 24 | $-0.12 | $-0.56 | ||
| Q3 24 | $-0.48 | $-0.34 | ||
| Q2 24 | $-0.75 | $-0.40 | ||
| Q1 24 | $-0.45 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $12.9M | $743.3M |
| 总债务越低越好 | $34.6M | $9.6M |
| 股东权益账面价值 | $18.2M | $1.1B |
| 总资产 | $89.1M | $1.5B |
| 负债/权益比越低杠杆越低 | 1.90× | 0.01× |
8季度趋势,按日历期对齐
现金及短期投资
FLNT
RXRX
| Q4 25 | $12.9M | $743.3M | ||
| Q3 25 | $9.2M | $659.8M | ||
| Q2 25 | $4.9M | $525.1M | ||
| Q1 25 | $4.8M | $500.5M | ||
| Q4 24 | $9.4M | $594.4M | ||
| Q3 24 | $6.6M | $427.6M | ||
| Q2 24 | $5.0M | $474.3M | ||
| Q1 24 | $11.7M | $296.3M |
总债务
FLNT
RXRX
| Q4 25 | $34.6M | $9.6M | ||
| Q3 25 | $26.0M | $11.9M | ||
| Q2 25 | $23.2M | $14.2M | ||
| Q1 25 | $25.6M | $16.4M | ||
| Q4 24 | $35.6M | $19.0M | ||
| Q3 24 | $37.9M | $20.5M | ||
| Q2 24 | $33.3M | $22.9M | ||
| Q1 24 | $31.0M | — |
股东权益
FLNT
RXRX
| Q4 25 | $18.2M | $1.1B | ||
| Q3 25 | $21.6M | $1.0B | ||
| Q2 25 | $19.1M | $919.1M | ||
| Q1 25 | $22.0M | $933.9M | ||
| Q4 24 | $25.0M | $1.0B | ||
| Q3 24 | $20.0M | $524.6M | ||
| Q2 24 | $27.5M | $584.4M | ||
| Q1 24 | $28.7M | $401.2M |
总资产
FLNT
RXRX
| Q4 25 | $89.1M | $1.5B | ||
| Q3 25 | $76.1M | $1.4B | ||
| Q2 25 | $74.5M | $1.3B | ||
| Q1 25 | $77.5M | $1.3B | ||
| Q4 24 | $93.6M | $1.4B | ||
| Q3 24 | $77.5M | $726.5M | ||
| Q2 24 | $98.5M | $775.9M | ||
| Q1 24 | $103.6M | $557.8M |
负债/权益比
FLNT
RXRX
| Q4 25 | 1.90× | 0.01× | ||
| Q3 25 | 1.21× | 0.01× | ||
| Q2 25 | 1.21× | 0.02× | ||
| Q1 25 | 1.16× | 0.02× | ||
| Q4 24 | 1.43× | 0.02× | ||
| Q3 24 | 1.90× | 0.04× | ||
| Q2 24 | 1.21× | 0.04× | ||
| Q1 24 | 1.08× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $2.8M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | — | $-47.3M |
| 自由现金流率自由现金流/营收 | — | -133.1% |
| 资本支出强度资本支出/营收 | — | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-378.3M |
8季度趋势,按日历期对齐
经营现金流
FLNT
RXRX
| Q4 25 | $2.8M | $-46.1M | ||
| Q3 25 | $-7.3M | $-117.4M | ||
| Q2 25 | $935.0K | $-76.4M | ||
| Q1 25 | $2.1M | $-132.0M | ||
| Q4 24 | $-2.1M | $-115.4M | ||
| Q3 24 | $1.2M | $-59.2M | ||
| Q2 24 | $-13.1M | $-82.2M | ||
| Q1 24 | $-132.0K | $-102.3M |
自由现金流
FLNT
RXRX
| Q4 25 | — | $-47.3M | ||
| Q3 25 | $-7.3M | $-117.6M | ||
| Q2 25 | — | $-79.6M | ||
| Q1 25 | — | $-133.8M | ||
| Q4 24 | — | $-116.7M | ||
| Q3 24 | $1.2M | $-63.8M | ||
| Q2 24 | — | $-83.4M | ||
| Q1 24 | — | $-109.0M |
自由现金流率
FLNT
RXRX
| Q4 25 | — | -133.1% | ||
| Q3 25 | -15.6% | -2272.5% | ||
| Q2 25 | — | -413.9% | ||
| Q1 25 | — | -907.4% | ||
| Q4 24 | — | -2567.7% | ||
| Q3 24 | 1.9% | -244.6% | ||
| Q2 24 | — | -578.5% | ||
| Q1 24 | — | -789.9% |
资本支出强度
FLNT
RXRX
| Q4 25 | — | 3.5% | ||
| Q3 25 | 0.0% | 4.7% | ||
| Q2 25 | — | 16.4% | ||
| Q1 25 | — | 12.4% | ||
| Q4 24 | — | 28.6% | ||
| Q3 24 | 0.0% | 17.5% | ||
| Q2 24 | — | 8.2% | ||
| Q1 24 | — | 48.2% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FLNT
| Commerce Media Solutions | $34.7M | 56% |
| Owned And Operated | $21.3M | 34% |
| Call Solutions | $3.8M | 6% |
| Ad Parlor | $2.0M | 3% |
RXRX
暂无分部数据